{"id":"https://openalex.org/W1978130556","doi":"https://doi.org/10.1111/dom.12097","title":"Superior glycaemic control with once\u2010daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial","display_name":"Superior glycaemic control with once\u2010daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial","publication_year":2013,"publication_date":"2013-03-14","ids":{"openalex":"https://openalex.org/W1978130556","doi":"https://doi.org/10.1111/dom.12097","mag":"1978130556","pmid":"https://pubmed.ncbi.nlm.nih.gov/23557077"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12097","doi":"https://doi.org/10.1111/dom.12097","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12097","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12097","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12097","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087983151","display_name":"Yukiko Onishi","orcid":"https://orcid.org/0000-0003-1180-5982","observed_orcids":["https://orcid.org/0000-0003-1180-5982"]},"institutions":[{"id":"https://openalex.org/I4210087332","display_name":"The Institute of Medical Science, Asahi Life Foundation","ror":"https://ror.org/000hskt11","country_code":"JP","type":"other","lineage":["https://openalex.org/I4210087332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Onishi","raw_affiliation_strings":["The Institute for Adult Diseases Asahi Life Foundation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute for Adult Diseases Asahi Life Foundation Tokyo Japan","institution_ids":["https://openalex.org/I4210087332"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y. Ono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284961","display_name":"Takagi Hospital","ror":"https://ror.org/04hdnvg05","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284961"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Ono","raw_affiliation_strings":["Internal Medicine Takagi Hospital Fukuoka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine Takagi Hospital Fukuoka Japan","institution_ids":["https://openalex.org/I4405284961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015825687","display_name":"Rasmus Rab\u00f8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"R. Rab\u00f8l","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033853646","display_name":"Lars A. Endahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"L. Endahl","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023832858","display_name":"Sadako NAKAMURA","orcid":"https://orcid.org/0000-0002-1009-9257","observed_orcids":["https://orcid.org/0000-0002-1009-9257"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Nakamura","raw_affiliation_strings":["Internal Medicine Heiwadai Hospital Miyazaki Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine Heiwadai Hospital Miyazaki Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015825687"],"corresponding_institution_ids":["https://openalex.org/I189090001"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":6.0614,"has_fulltext":true,"cited_by_count":97,"citation_normalized_percentile":{"value":0.97118216,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"15","issue":"9","first_page":"826","last_page":"832"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.11270000040531158,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-degludec-insulin-aspart","display_name":"IDegAsp","score":0.9890000224113464},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8029999732971191},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.6710000038146973},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.6840000152587891},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.4909999966621399},{"id":"https://openalex.org/keywords/japanese-adults","display_name":"Japanese adults","score":0.5230000019073486},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.7319999933242798},{"id":"https://openalex.org/keywords/insulin-dose","display_name":"insulin dose","score":0.3970000147819519},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9020000100135803},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6850000023841858},{"id":"https://openalex.org/keywords/treat-to-target","display_name":"treat-to-target","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6688162684440613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6517731547355652},{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.6374620199203491},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6078189015388489},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.5833679437637329},{"id":"https://openalex.org/C2775927303","wikidata":"https://www.wikidata.org/wiki/Q16252338","display_name":"Insulin degludec","level":5,"score":0.5704227089881897},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5556386709213257},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5096864700317383},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4286923110485077}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12097","doi":"https://doi.org/10.1111/dom.12097","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12097","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12097","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:23557077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23557077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/dom.12097","doi":"https://doi.org/10.1111/dom.12097","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12097","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12097","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978130556.pdf","grobid_xml":"https://content.openalex.org/works/W1978130556.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W1565099151","https://openalex.org/W1986874694","https://openalex.org/W1994787546","https://openalex.org/W2050756416","https://openalex.org/W2053830590","https://openalex.org/W2054654761","https://openalex.org/W2056526409","https://openalex.org/W2079023387","https://openalex.org/W2106459655","https://openalex.org/W2109533147","https://openalex.org/W2129512027","https://openalex.org/W2147405776","https://openalex.org/W2190748907","https://openalex.org/W2199261925","https://openalex.org/W2917207274"],"related_works":["https://openalex.org/W2332567887","https://openalex.org/W2166393441","https://openalex.org/W2901955691","https://openalex.org/W2532403559","https://openalex.org/W2337646370","https://openalex.org/W2035760642","https://openalex.org/W1871019915","https://openalex.org/W1939761693","https://openalex.org/W2791768902","https://openalex.org/W1994662102"],"abstract_inverted_index":{"AIMS:":[0],"This":[1],"phase":[2],"3,":[3],"26-week,":[4],"open-label,":[5],"treat-to-target":[6],"trial":[7],"investigated":[8],"the":[9,54,58,66,204],"efficacy":[10],"and":[11,100,135,162,180,234,236,242],"safety":[12],"of":[13,33,60,85,105,158,240],"insulin":[14,39,191],"degludec/insulin":[15],"aspart":[16],"(IDegAsp)":[17],"in":[18,206],"insulin-na\u00efve":[19],"Japanese":[20],"adults":[21],"with":[22,98,102,154,231],"type":[23],"2":[24],"diabetes.":[25],"METHODS:":[26],"Subjects":[27],"were":[28,76,193,203,217],"randomized":[29],"to":[30,72,78,87,107,229],"once-daily":[31],"injections":[32],"IDegAsp":[34,50,99,106,134,151,222],"(n":[35,42],"=":[36,43,149,178,186,246],"147)":[37],"or":[38],"glargine":[40],"(IGlar)":[41],"149),":[44],"both":[45],"\u00b1\u22642":[46],"oral":[47],"antidiabetic":[48],"treatments.":[49],"was":[51,69,96,109,131,152],"given":[52],"before":[53],"largest":[55],"meal":[56],"at":[57,197],"discretion":[59],"each":[61],"subject":[62],"(and":[63],"maintained":[64],"throughout":[65],"trial);":[67],"IGlar":[68,108,136,168],"dosed":[70],"according":[71],"label.":[73],"Both":[74],"insulins":[75],"titrated":[77],"a":[79],"target":[80],"prebreakfast":[81],"self-measured":[82],"plasma":[83,128],"glucose":[84,129],"3.9":[86],"<5.0":[88],"mmol/l.":[89],"RESULTS:":[90],"After":[91],"26":[92],"weeks,":[93],"mean":[94,126],"HbA1c":[95],"7%":[97],"7.3%":[101],"IGlar;":[103],"superiority":[104],"shown":[110],"(estimated":[111,169],"treatment":[112],"difference,":[113],"ETD;":[114],"IDegAsp-IGlar:":[115,142],"-0.28%":[116],"points":[117],"[-0.46;":[118],"-0.10](95%":[119],"CI),":[120,147,176,184],"p":[121,148,177,185],"<":[122],"0.01).":[123],"At":[124],"end-of-trial,":[125],"fasting":[127],"(FPG)":[130],"similar":[132,194,218,232],"for":[133],"(5.7":[137],"vs.":[138],"5.6":[139],"mmol/l;":[140],"ETD":[141],"0.15":[143],"mmol/l":[144],"[-0.29;":[145],"0.60](95%":[146],"NS).":[150,247],"associated":[153],"numerically":[155,237],"lower":[156,238],"rates":[157,239],"overall":[159,241],"confirmed":[160,164],"(27%)":[161],"nocturnal":[163,243],"hypoglycaemia":[165,244],"(25%)":[166],"versus":[167],"rate":[170],"ratio":[171],"IDegAsp/IGlar:":[172],"0.73":[173],"[0.50;":[174],"1.08](95%":[175],"NS,":[179,187],"0.75":[181],"[0.34;":[182],"1.64](95%":[183],"respectively).":[188],"Mean":[189],"daily":[190],"doses":[192,235],"between":[195,219],"groups":[196],"end-of-trial":[198],"(both:":[199,211],"0.41":[200],"U/kg)":[201],"as":[202],"increases":[205],"body":[207],"weight":[208],"from":[209],"baseline":[210],"0.7":[212],"kg).":[213],"Adverse":[214],"event":[215],"profiles":[216],"groups.":[220],"CONCLUSIONS:":[221],"provided":[223],"superior":[224],"long-term":[225],"glycaemic":[226],"control":[227],"compared":[228],"IGlar,":[230],"FPG":[233],"(p":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}